Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion type Assertion NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_head.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion wasGeneratedBy ECO_0000203 NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_provenance.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion wasDerivedFrom gad-20150221 NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_provenance.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion SIO_000772 20733306 NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_provenance.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion evidence source_evidence_literature NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_provenance.
- NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_assertion description "[Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP133564.RAXCjAs6RgzielHzgSO0rI4fTaR3n1NvIqOSM4K9mKkVs130_provenance.